FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2143670703> ?p ?o ?g. }

• W2143670703 endingPage "129" @default.
• W2143670703 startingPage "121" @default.
• W2143670703 abstract "Background The prevalence of chronic heart failure (CHF) with systolic dysfunction is increasing. Plasma natriuretic peptides have been envisaged as diagnostic and predictive markers. Aims To investigate the relationship between the levels of B-type natriuretic peptide (BNP) and A-type natriuretic peptide (ANP) and the clinical and functional parameters of CHF in outpatients with CHF at baseline, compared with normal healthy controls; to find out the differences in a randomised controlled trial between patients treated with an angiotensin-converting enzyme (ACE) inhibitor, captopril, or an angiotensin receptor blocker (ARB), irbesartan. These differences were assessed throughout the six-month treatment period and at the sixth month. Methods Plasma BNP (pmol/L) and ANP (pmol/L) were determined in 68 hypertensive patients with dilated cardiomyopathy, NYHA class III-IV and ejection fraction (EF) <40%, and in 26 normal controls. Statistical analysis for BNP and ANP was done by Student's t-test. The patient group was randomly subdivided into two subgroups of 34 patients, each treated with either an ARB, irbesartan, or an ACE inhibitor (ACE-I), captopril. BNP and ANP were measured in both subsamples and correlated with clinical, functional and neurohormonal parameters throughout a follow-up period of six months and at the sixth month. Results The mean EF in the patient sample was 33.43±6.52% and in the controls was 61.96 ±3.53% (p=0.000). The mean BNP (pmol/L) in patients was 44.78±54.36 and in the controls was 7.12±8.28 (p=0.000) and the mean ANP (pmol/L) was 30.32±25.97 in patients and 11.18±7.92 in controls (p=0.000). A statistically significant difference was found between patients and healthy controls. Significant correlations were found between natriuretic peptides and EF. Between the baseline phase and the sixth month, BNP and ANP decreased significantly in the ARB group. At the sixth month, both BNP and ANP were lower in the ARB group. Evidence of clinical benefit was found with both ARB or ACE-I treatment throughout the six months, with patients moving from classes III and IV to class II NYHA. Improvement of EF was also found, with transition of patients with lower EF (even <30%) to higher values. EF was higher in the ARB group at the sixth month. Conclusions BNP and ANP can be useful diagnostic tools in hypertensive CHF patients with moderate-to-severe LV dysfunction. The decrease in BNP and ANP in the ARB group throughout six months, as well as the lower value at the sixth month, suggest a prognostic value of these parameters." @default.
• W2143670703 created "2016-06-24" @default.
• W2143670703 creator A5016901394 @default.
• W2143670703 creator A5036070337 @default.
• W2143670703 creator A5075844136 @default.
• W2143670703 creator A5090903455 @default.
• W2143670703 date "2004-09-01" @default.
• W2143670703 modified "2023-10-16" @default.
• W2143670703 title "BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction" @default.
• W2143670703 cites W1852784462 @default.
• W2143670703 cites W1984123284 @default.
• W2143670703 cites W1995406808 @default.
• W2143670703 cites W1997062534 @default.
• W2143670703 cites W1997610845 @default.
• W2143670703 cites W2000287422 @default.
• W2143670703 cites W2012831843 @default.
• W2143670703 cites W2015362975 @default.
• W2143670703 cites W2016162102 @default.
• W2143670703 cites W2016768719 @default.
• W2143670703 cites W2016782456 @default.
• W2143670703 cites W2018433250 @default.
• W2143670703 cites W2019605946 @default.
• W2143670703 cites W2023136374 @default.
• W2143670703 cites W2027837958 @default.
• W2143670703 cites W2029379316 @default.
• W2143670703 cites W2029440711 @default.
• W2143670703 cites W2032385834 @default.
• W2143670703 cites W2033708923 @default.
• W2143670703 cites W2043414532 @default.
• W2143670703 cites W2048664109 @default.
• W2143670703 cites W2054708573 @default.
• W2143670703 cites W2058209034 @default.
• W2143670703 cites W2058352871 @default.
• W2143670703 cites W2058919102 @default.
• W2143670703 cites W2065059934 @default.
• W2143670703 cites W2072067798 @default.
• W2143670703 cites W2075699728 @default.
• W2143670703 cites W2081713698 @default.
• W2143670703 cites W2085336412 @default.
• W2143670703 cites W2100082183 @default.
• W2143670703 cites W2106990917 @default.
• W2143670703 cites W2120561016 @default.
• W2143670703 cites W2121245510 @default.
• W2143670703 cites W2122756617 @default.
• W2143670703 cites W2123671822 @default.
• W2143670703 cites W2126834790 @default.
• W2143670703 cites W2143540423 @default.
• W2143670703 cites W2161515908 @default.
• W2143670703 cites W2164316901 @default.
• W2143670703 cites W2338638760 @default.
• W2143670703 cites W2340670561 @default.
• W2143670703 doi "https://doi.org/10.3317/jraas.2004.028" @default.
• W2143670703 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15526247" @default.
• W2143670703 hasPublicationYear "2004" @default.
• W2143670703 type Work @default.
• W2143670703 sameAs 2143670703 @default.
• W2143670703 citedByCount "27" @default.
• W2143670703 countsByYear W21436707032012 @default.
• W2143670703 countsByYear W21436707032015 @default.
• W2143670703 countsByYear W21436707032017 @default.
• W2143670703 countsByYear W21436707032018 @default.
• W2143670703 countsByYear W21436707032020 @default.
• W2143670703 countsByYear W21436707032021 @default.
• W2143670703 countsByYear W21436707032022 @default.
• W2143670703 countsByYear W21436707032023 @default.
• W2143670703 crossrefType "journal-article" @default.
• W2143670703 hasAuthorship W2143670703A5016901394 @default.
• W2143670703 hasAuthorship W2143670703A5036070337 @default.
• W2143670703 hasAuthorship W2143670703A5075844136 @default.
• W2143670703 hasAuthorship W2143670703A5090903455 @default.
• W2143670703 hasConcept C126322002 @default.
• W2143670703 hasConcept C134018914 @default.
• W2143670703 hasConcept C164705383 @default.
• W2143670703 hasConcept C27016395 @default.
• W2143670703 hasConcept C2775846464 @default.
• W2143670703 hasConcept C2775915353 @default.
• W2143670703 hasConcept C2776383484 @default.
• W2143670703 hasConcept C2778069365 @default.
• W2143670703 hasConcept C2778198053 @default.
• W2143670703 hasConcept C2778797674 @default.
• W2143670703 hasConcept C2779479957 @default.
• W2143670703 hasConcept C2779611605 @default.
• W2143670703 hasConcept C2780259554 @default.
• W2143670703 hasConcept C71924100 @default.
• W2143670703 hasConcept C78085059 @default.
• W2143670703 hasConcept C84393581 @default.
• W2143670703 hasConceptScore W2143670703C126322002 @default.
• W2143670703 hasConceptScore W2143670703C134018914 @default.
• W2143670703 hasConceptScore W2143670703C164705383 @default.
• W2143670703 hasConceptScore W2143670703C27016395 @default.
• W2143670703 hasConceptScore W2143670703C2775846464 @default.
• W2143670703 hasConceptScore W2143670703C2775915353 @default.
• W2143670703 hasConceptScore W2143670703C2776383484 @default.
• W2143670703 hasConceptScore W2143670703C2778069365 @default.
• W2143670703 hasConceptScore W2143670703C2778198053 @default.
• W2143670703 hasConceptScore W2143670703C2778797674 @default.
• W2143670703 hasConceptScore W2143670703C2779479957 @default.
• W2143670703 hasConceptScore W2143670703C2779611605 @default.

• next